Research & Development
AbbVie and Allergan announce divestment of brazikumab and Zenpep
27 January 2020 - Research-based global biopharmaceutical company AbbVie (NYSE:ABBV) and pharmaceutical company Allergan (NYSE:AGN) revealed on Monday that Allergan has signed definitive agreements to...
Onco360 to launch TAZVERIK for the treatment of epithelioid sarcoma
27 January 2020 - Oncology pharmacy Onco360 stated on Friday that it will market TAZVERIK (Tazemetostat) for treatment of patients with epithelioid sarcoma under the exclusive specialty pharmacy partn...
Pfizer's Greenstone and Digital Men's Health Clinic Roman Collaborate to Offer Patients Remote Access to the Only FDA-Approved Authorized Generic Version of Viagra 
24 January 2020 - - US-based Greenstone, Upjohn's US-based generics business and a wholly owned subsidiary of Pfizer Inc., and Roman, a digital healthcare clinic for men, have inked a supply agre...
The New England Journal of Medicine Publishes Comprehensive Data from Phase 3 Clinical Trial (OPTIC) of Tapezza for Thyroid Eye Disease
24 January 2020 - - The New England Journal of Medicine has published comprehensive results of the Phase 3 OPTIC clinical trial evaluating Tapezza (teprotumumab-trbw) for Thyroid E...
The FDA announces accelerated approval for first treatment option for patients with epithelioid sarcoma
24 January 2020 - Public health agency The US Food and Drug Administration Thursday awarded the accelerated approval for Tazverik (tazemetostat) for the treatment of adults and pediatric patients aged...
PledPharma reports issue by FDA of clinical hold in US on phase III POLAR programme
24 January 2020 - PledPharma AB (STO: PLED), an integrated pharmaceutical drug development company, announced on Thursday that the US Food and Drug Administration (FDA) has issued a clinical hold in t...